Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
  • The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025.  The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.  
  • ​UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077.  For SDU business hours, click here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 2, 2010

Drug Name Review Type Class Manufacturer
Victoza New Drug Initial Review GLP-1 Receptor Agonist Novo Nordisk
Kalbitor New Drug Initial Review Orphan Biologic � for HAE Dyax
Intuniv New Drug Initial Review ADHD Agents Shire
Fanapt New Drug Initial Review Atypical Antipsychotic Novartis
Effient New Drug Initial Review Platelet Aggregation Inhibitor Eli Lilly
Ampyra New Drug Initial Review Multiple Sclerosis Agents Acorda
Xifaxan 550 New Drug Initial Review Antibiotic Salix
Cayston New Drug Initial Review Antibiotic Gilead
Renvela New Drug Appeal Phosphate Binder Genzyme
Byetta New Drug Appeal GLP-1 Receptor Agonist Amylin
Invega Sustenna New Drug Appeal Atypical Antipsychotic Ortho McNeil Janssen
Multaq New Drug Appeal Antiarrhythmic Sanofi
Twynsta New Drug Appeal Antihypertensive Combination Boehringer Ingelheim
Zemplar New Drug Appeal Hyperparathyroidism due to CKD Abbott
Toviaz New Drug Appeal Urinary Anti-Incontinence Pfizer
Vivitrol New Drug Appeal Opioid Antagonist Alkermes